Clinical Trials Browser

Phase 2 × HER2-positive Advanced Breast Cancer × ribociclib × Clear all

NCT06481956 2024-07-01

T-DM1 Combined With CDK4/6 Inhibitor Ribociclib

Phase 2 Enrolling by invitation

HER2-positive Advanced Breast Cancer